Effects of leptin, troglitazone, and dietary fat on stearoyl CoA desaturase

Tetsuya Kakuma, Young H Lee, Roger H Unger

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Leptin, troglitazone, and high fat feeding profoundly influence the lipid content of various tissues. To determine if they affect the expression of stearoyl CoA desaturase (SCD)-1 and -2, their mRNA was measured in livers of normal, hyperleptinemic, troglitazone-treated, and fat-fed rats. Hyperleptinemia, which reduces tissue TG by downregulating lipogenic enzymes and upregulating fatty acid oxidation, lowered SCD-1 96% below controls and reduced SCD-2 slightly. By contrast, hepatic SCD-1 mRNA of leptin-resistant fa/fa rats was five times wild-type controls, but SCD-2 mRNA was 66% lower. High fat feeding lowered SCD-1 by 80%, possibly by inducing hyperleptinemia. Troglitazone treatment, which reduces nonadipose tissue TG of fa/fa rats without down-regulating lipogenic enzymes, raised SCD-2 13-fold but lowered SCD-1 by 25%. The findings suggest that leptin controls SCD-1 expression and that troglitazone's antilipotoxic action may involve SCD-2 upregulation.

Original languageEnglish (US)
Pages (from-to)1259-1263
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume297
Issue number5
DOIs
StatePublished - 2002

Fingerprint

troglitazone
Stearoyl-CoA Desaturase
Dietary Fats
Leptin
Rats
Fats
Tissue
Messenger RNA
Liver

Keywords

  • Ceramide
  • Diet-induced obesity
  • Leptin
  • Lipotoxicity
  • Stearoyl CoA desaturase
  • Thiazolidinediones
  • Troglitazone

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Effects of leptin, troglitazone, and dietary fat on stearoyl CoA desaturase. / Kakuma, Tetsuya; Lee, Young H; Unger, Roger H.

In: Biochemical and Biophysical Research Communications, Vol. 297, No. 5, 2002, p. 1259-1263.

Research output: Contribution to journalArticle

@article{aab79539e88745b68023659f688d1d72,
title = "Effects of leptin, troglitazone, and dietary fat on stearoyl CoA desaturase",
abstract = "Leptin, troglitazone, and high fat feeding profoundly influence the lipid content of various tissues. To determine if they affect the expression of stearoyl CoA desaturase (SCD)-1 and -2, their mRNA was measured in livers of normal, hyperleptinemic, troglitazone-treated, and fat-fed rats. Hyperleptinemia, which reduces tissue TG by downregulating lipogenic enzymes and upregulating fatty acid oxidation, lowered SCD-1 96{\%} below controls and reduced SCD-2 slightly. By contrast, hepatic SCD-1 mRNA of leptin-resistant fa/fa rats was five times wild-type controls, but SCD-2 mRNA was 66{\%} lower. High fat feeding lowered SCD-1 by 80{\%}, possibly by inducing hyperleptinemia. Troglitazone treatment, which reduces nonadipose tissue TG of fa/fa rats without down-regulating lipogenic enzymes, raised SCD-2 13-fold but lowered SCD-1 by 25{\%}. The findings suggest that leptin controls SCD-1 expression and that troglitazone's antilipotoxic action may involve SCD-2 upregulation.",
keywords = "Ceramide, Diet-induced obesity, Leptin, Lipotoxicity, Stearoyl CoA desaturase, Thiazolidinediones, Troglitazone",
author = "Tetsuya Kakuma and Lee, {Young H} and Unger, {Roger H}",
year = "2002",
doi = "10.1016/S0006-291X(02)02375-6",
language = "English (US)",
volume = "297",
pages = "1259--1263",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of leptin, troglitazone, and dietary fat on stearoyl CoA desaturase

AU - Kakuma, Tetsuya

AU - Lee, Young H

AU - Unger, Roger H

PY - 2002

Y1 - 2002

N2 - Leptin, troglitazone, and high fat feeding profoundly influence the lipid content of various tissues. To determine if they affect the expression of stearoyl CoA desaturase (SCD)-1 and -2, their mRNA was measured in livers of normal, hyperleptinemic, troglitazone-treated, and fat-fed rats. Hyperleptinemia, which reduces tissue TG by downregulating lipogenic enzymes and upregulating fatty acid oxidation, lowered SCD-1 96% below controls and reduced SCD-2 slightly. By contrast, hepatic SCD-1 mRNA of leptin-resistant fa/fa rats was five times wild-type controls, but SCD-2 mRNA was 66% lower. High fat feeding lowered SCD-1 by 80%, possibly by inducing hyperleptinemia. Troglitazone treatment, which reduces nonadipose tissue TG of fa/fa rats without down-regulating lipogenic enzymes, raised SCD-2 13-fold but lowered SCD-1 by 25%. The findings suggest that leptin controls SCD-1 expression and that troglitazone's antilipotoxic action may involve SCD-2 upregulation.

AB - Leptin, troglitazone, and high fat feeding profoundly influence the lipid content of various tissues. To determine if they affect the expression of stearoyl CoA desaturase (SCD)-1 and -2, their mRNA was measured in livers of normal, hyperleptinemic, troglitazone-treated, and fat-fed rats. Hyperleptinemia, which reduces tissue TG by downregulating lipogenic enzymes and upregulating fatty acid oxidation, lowered SCD-1 96% below controls and reduced SCD-2 slightly. By contrast, hepatic SCD-1 mRNA of leptin-resistant fa/fa rats was five times wild-type controls, but SCD-2 mRNA was 66% lower. High fat feeding lowered SCD-1 by 80%, possibly by inducing hyperleptinemia. Troglitazone treatment, which reduces nonadipose tissue TG of fa/fa rats without down-regulating lipogenic enzymes, raised SCD-2 13-fold but lowered SCD-1 by 25%. The findings suggest that leptin controls SCD-1 expression and that troglitazone's antilipotoxic action may involve SCD-2 upregulation.

KW - Ceramide

KW - Diet-induced obesity

KW - Leptin

KW - Lipotoxicity

KW - Stearoyl CoA desaturase

KW - Thiazolidinediones

KW - Troglitazone

UR - http://www.scopus.com/inward/record.url?scp=0036402144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036402144&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(02)02375-6

DO - 10.1016/S0006-291X(02)02375-6

M3 - Article

C2 - 12372423

AN - SCOPUS:0036402144

VL - 297

SP - 1259

EP - 1263

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 5

ER -